Skip to main content
. 2017 Aug 3;76(1):1340547. doi: 10.1080/22423982.2017.1340547

Table 2.

The results (mean, maximum, minimum and p-values) of the investigations following 3 months of treatment compared with the results at baseline.

  Baseline
Following 3 mos of treatment
Difference of Significance
  Mean Min. Max. n Mean Min. Max. n the means  P-value
25(OH)D (nmol/L) 20.0 10 38 21 61.3 36 119 19 41.3 <0.001
PTH (nmol/L) 80.4 22 175 21 47.3 18 110 21 −33.1 0.004
Rated pain in VAS (cm) 5.7 2 10 19 3.2 0 7 18 −2.5 0.005
Chair stand test (s) 23.4 12 37 21 19.7 11 29 20 −3.7 <0.001
Bone tenderness (kPa) 567.7 210 876 17 542.5 239 882 −25.2  0.470

VAS, visual analogue scale; PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D.